• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A ratio-to-control Williams-type test for trend.

作者信息

Hothorn Ludwig A, Djira Gemechis D

机构信息

Institute of Biostatistics, Leibniz University of Hannover, Hannover, Germany.

出版信息

Pharm Stat. 2011 Jul-Aug;10(4):289-92. doi: 10.1002/pst.464. Epub 2010 Oct 11.

DOI:10.1002/pst.464
PMID:20936714
Abstract

Under certain conditions, many multiple contrast tests based on the difference of treatment means can also be conveniently expressed in terms of ratios. In this paper, a Williams test for trend is defined as ratios-to-control for ease of interpretation and to obtain directly comparable confidence intervals. Simultaneous confidence intervals for percentages are particularly helpful for interpretations in the case of multiple endpoints. Methods for constructing simultaneous confidence intervals are discussed under both homogeneous and heterogeneous error variances. This approach is available in the R extension package mratios. The proposed method is used to test for trend in an immunotoxicity study with several endpoints as an example.

摘要

相似文献

1
A ratio-to-control Williams-type test for trend.
Pharm Stat. 2011 Jul-Aug;10(4):289-92. doi: 10.1002/pst.464. Epub 2010 Oct 11.
2
How to deal with multiple treatment or dose groups in randomized clinical trials?如何在随机临床试验中处理多个治疗组或剂量组?
Fundam Clin Pharmacol. 2007 Apr;21(2):137-54. doi: 10.1111/j.1472-8206.2007.00469.x.
3
Multiple contrast tests for multiple endpoints in the presence of heteroscedasticity.存在异方差性时针对多个终点的多重对比检验。
Int J Biostat. 2014;10(1):17-28. doi: 10.1515/ijb-2012-0015.
4
Poly-k-trend tests for survival adjusted analysis of tumor rates formulated as approximate multiple contrast test.
J Biopharm Stat. 2008;18(5):934-48. doi: 10.1080/10543400802294285.
5
Multiple comparisons and multiple contrasts in randomized dose-response trials--confidence interval oriented approaches.随机剂量反应试验中的多重比较和多重对比——以置信区间为导向的方法
J Biopharm Stat. 2006;16(5):711-31. doi: 10.1080/10543400600860576.
6
Applying the law of iterated logarithm to control type I error in cumulative meta-analysis of binary outcomes.应用重对数律控制二分类结局累积Meta分析中的I型错误。
Clin Trials. 2007;4(4):329-40. doi: 10.1177/1740774507081219.
7
Confidence intervals and p-values for Williams' and other step-down multiple comparison tests against control.针对对照组的威廉姆斯检验及其他逐步下调多重比较检验的置信区间和p值。
J Biopharm Stat. 2001 Feb-May;11(1-2):45-63. doi: 10.1081/BIP-100104197.
8
An efficient and exact approach for detecting trends with binary endpoints.一种用于检测二分类结局趋势的高效准确方法。
Stat Med. 2012 Jan 30;31(2):155-64. doi: 10.1002/sim.4411. Epub 2011 Dec 9.
9
A ratio test in active control non-inferiority trials with a time-to-event endpoint.具有事件发生时间终点的活性对照非劣效性试验中的比值检验。
J Biopharm Stat. 2006;16(2):151-64. doi: 10.1080/10543400500508754.
10
Sequential monitoring of clinical trials with multiple survival endpoints.对具有多个生存终点的临床试验进行序贯监测。
Stat Med. 1996;15(21-22):2341-57; discussion 2367-70. doi: 10.1002/(SICI)1097-0258(19961115)15:21<2341::AID-SIM453>3.0.CO;2-N.